Detalhe da pesquisa
1.
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients.
BMC Cancer
; 20(1): 558, 2020 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546141
2.
Novel pyrimidine-2,4-diamine derivative suppresses the cell viability and spindle assembly checkpoint activity by targeting Aurora kinases.
Carcinogenesis
; 34(2): 436-45, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23104179
3.
The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis.
Exp Cell Res
; 318(5): 578-92, 2012 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22227008
4.
ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics.
Front Neurol
; 13: 826423, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35222254
5.
Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen.
BMJ Open
; 12(10): e064695, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198465
6.
VTT-006, an anti-mitotic compound, binds to the Ndc80 complex and suppresses cancer cell growth in vitro.
Oncoscience
; 8: 134-153, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926718
7.
Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Mol Cell Endocrinol
; 301(1-2): 216-24, 2009 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014997
8.
Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.
Mol Cancer Ther
; 13(5): 1054-66, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24748653